P. Spark

Carvedilol protects better against vascular events than metoprolol in heart failure: results from COMET.

P. Poole‐Wilson, K. Swedberg, J. Cleland, 2007, Journal of the American College of Cardiology.

Prognostic importance of plasma NT‐pro BNP in chronic heart failure in patients treated with a β‐blocker: Results from the Carvedilol Or Metoprolol European Trial (COMET) trial

P. Poole‐Wilson, K. Swedberg, L. Olsson, 2007, European journal of heart failure.

Effect of carvedilol and metoprolol on the mode of death in patients with heart failure

P. Poole‐Wilson, K. Swedberg, M. Metra, 2007, European journal of heart failure.